IVZUMAB 100MG INJECTION

About IVZUMAB 100MG INJECTION

Ivzumab 100MG Injection contains bevacizumab 100mg. It blocks VEGF, a signal tumours use to grow new blood vessels, so the tumour is starved of blood supply, which is why it is classed as an anti-VEGF monoclonal antibody (targeted therapy). Specialists use it for metastatic colorectal cancer, non-small cell lung cancer, ovarian, cervical and kidney cancer, and glioblastoma. During treatment expect regular checks such as blood pressure and urine protein checks before each dose. Made by RPG Life Sciences; pack size 1 vial. MRP Rs 4,493 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.